A funding round has pulled in $10 million for Zyga Technology, maker of the FDA-cleared SImmetry Sacroiliac Joint Fusion System designed to treat hip and lower back pain. The company also hopes to obtain CE mark approval in Europe for its Glyder Facet Resurfacing System, which is used to treat chronic facetogenic pain, by the close of the year.
Zyga gets $10M boost, expects CE mark for Glyder device by year's end
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||